Sullivan Timothy Eugene

Average Profitability
1.94%
Insider Buys Quantity
1
Insider Buys Sum
$695,259.87
Insider Sells Quantity
10
Insider Sells Sum
$12.09M

Insider Activity of Sullivan Timothy Eugene

According to the SEC Form 4 filings, Sullivan Timothy Eugene, being in a position of

  1. Chief Financial Officer at Apellis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18123 shares for $1.15M,
    over all time since 2019-08-29, has bought 23398 shares for $695,260, and sold 146409 shares for $12.09M.

The largest purchase of all time was on 2019-08-29 and amounted to 23398 shares of Apellis Pharmaceuticals, Inc. for $695,260.

The largest sale of all time was on 2023-06-05 and amounted to 37570 shares of Apellis Pharmaceuticals, Inc. for $3.36M.

Biography of Sullivan Timothy Eugene

No biography is available at this moment.

2024-04-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
4,000
0.0033%
$58.66$234,640-35.09%
2024-03-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
6,000
0.0049%
$63.22$379,340-38.12%
2024-02-12SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
1,431
0.0012%
$67.77$96,974-41.18%
2024-01-29SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
906
0.0008%
$64.14$58,109-38.56%
2024-01-22SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
3,551
0.003%
$65.00$230,801-38.19%
2024-01-16SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
2,235
0.0019%
$66.81$149,317-39.28%
2023-11-30SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
14,158
0.0122%
$54.73$774,884-18.95%
2023-07-03SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
6,779
0.006%
$89.97$609,928-46.1%
2023-06-05SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
37,570
0.0329%
$89.55$3.36M-44.47%
2023-06-05SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
69,779
0.0606%
$88.80$6.2M-44.47%
2019-08-29PurchaseApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
23,398
0.0367%
$29.71$695,260+1.94%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.